Top Irhythm Executives Quietly Unload a Major Chunk of Company Stock
TipRanks (Tue, 11-Aug 10:02 PM ET)
iRhythm edges lower amid Spruce Point short comments
Seeking Alpha News (Tue, 11-Aug 2:33 PM ET)
iRhythm edges lower amid Spruce Point short call
Seeking Alpha News (Tue, 11-Aug 2:33 PM ET)
Truist Financial Sticks to Their Buy Rating for Irhythm Technologies (IRTC)
TipRanks (Mon, 10-Aug 7:55 AM ET)
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
PRNewswire (Sat, 8-Aug 3:36 PM ET)
TipRanks (Fri, 7-Aug 3:50 PM ET)
Market Chameleon (Fri, 7-Aug 6:43 AM ET)
iRhythm rises after Q2 beat and Vital Connect buyout
Seeking Alpha News (Fri, 7-Aug 9:04 AM ET)
Oppenheimer Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)
TipRanks (Fri, 7-Aug 8:28 AM ET)
Needham Remains a Buy on Irhythm Technologies (IRTC)
TipRanks (Fri, 7-Aug 7:28 AM ET)
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Irhythm Holdings trades on the NASDAQ stock market under the symbol IRTC.
As of August 12, 2026, IRTC stock price climbed to $125.35 with 945,027 million shares trading.
IRTC has a beta of 0.87, meaning it tends to be less sensitive to market movements. IRTC has a correlation of 0.08 to the broad based SPY ETF.
IRTC has a market cap of $4.12 billion. This is considered a Mid Cap stock.
Last quarter Irhythm Holdings reported $224 million in Revenue and $.58 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.59.
In the last 3 years, IRTC traded as high as $212.00 and as low as $55.92.
The top ETF exchange traded funds that IRTC belongs to (by Net Assets): VTI, IWM, VB, VBK, VXF.
IRTC has underperformed the market in the last year with a return of -21.9%, while SPY returned +22.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in IRTC shares. However, IRTC has outperformed the market in the last 3 month and 2 week periods, returning +7.3% and +6.8%, while SPY returned +4.7% and +4.3%, respectively. This indicates IRTC has been having a stronger performance recently.
IRTC support price is $118.41 and resistance is $125.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IRTC shares will trade within this expected range on the day.